OS Therapies (OSTX) Current Assets (2023 - 2026)
OS Therapies' (OSTX) quarterly Current Assets came in at $917552.0 in Q1 2026, down 77.6% YoY from $4.1 million in Q1 2025, and up 175.61% on a QoQ basis from $332912.0 in Q4 2025.
OS Therapies (OSTX) Current Assets (2023 - 2026) Analysis & Trends
OS Therapies (OSTX) has 4 years of Current Assets data on file, last reported at $917552.0 in Q1 2026.
- Quarterly Current Assets fell 77.6% year-over-year to $917552.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $917552.0 (down 77.6% YoY) and the FY2025 annual result came in at $332912.0, down 93.98% from the prior year.
- Current Assets rose to $917552.0 in Q1 2026, from $332912.0 in the prior quarter.
- In the past five years, Current Assets ranged from a high of $5.5 million in Q4 2024 to a low of $332912.0 in Q4 2025.
- A 4-year average of $2.2 million and a median of $1.7 million in 2024 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2024 — Current Assets soared 600.42% — and 2025, when it sank 93.98%.
- Tracing OSTX's Current Assets over 4 years: stood at $790032.0 in 2023, then soared by 600.42% to $5.5 million in 2024, then slumped by 93.98% to $332912.0 in 2025, then surged by 175.61% to $917552.0 in 2026.
- The last three Current Assets figures came in at $917552.0 (Q1 2026), $332912.0 (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | OS Therapies | 19.56 Mn | 19.56 Mn | - | 3.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 917,552.00 |
| Dec 31, 2025 | 332,912.00 |
| Sep 30, 2025 | 2.32 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 4.10 Mn |
| Dec 31, 2024 | 5.53 Mn |
| Sep 30, 2024 | 1.97 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.04 Mn |
| Dec 31, 2023 | 790,032.00 |